Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates

Company Performance - Myomo, Inc. reported a quarterly loss of $0.01 per share, better than the Zacks Consensus Estimate of a loss of $0.02, and an improvement from a loss of $0.07 per share a year ago, representing an earnings surprise of 50% [1] - The company posted revenues of $12.07 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 24.54%, compared to year-ago revenues of $4.76 million [2] - Over the last four quarters, Myomo has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Performance - Myomo shares have declined approximately 28.6% since the beginning of the year, while the S&P 500 has only declined by 1.9% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.07 on revenues of $6.8 million, and for the current fiscal year, it is -$0.07 on revenues of $37.22 million [7] Industry Outlook - The Medical - Products industry, to which Myomo belongs, is currently ranked in the bottom 45% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Myomo's stock performance [5]